WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today announced the initial selection of presenting companies for the 14th Annual BIO CEO & Investor Conference to be held February 13 – 14, 2012 in New York City. “As the largest independent investor conference focused solely on publicly-traded biotechnology companies, this event provides an ideal platform for companies to present their story to investors, analysts, and potential corporate partners,” said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development at BIO.
